| Name | Title | Contact Details |
|---|
Petvisor is a company that delivers a suite of mobile-enabled technologies to pet care professionals, helping them care for pet families. They provide tools to engage customers, streamline operations, and grow businesses in the veterinary health and pe...
Lakeland Care is a Wisconsin-based managed care organization that provides long term care services and supports to eligible frail elders and individuals with physical and intellectual/developmental disabilities through Wisconsins Family Care program.
ITC is a wholly-owned subsidiary of Thoratec and develops, manufactures and markets medical devices used in three distinct segments of the medical field.
Furiex Pharmaceuticals, Inc., a drug development company, engages in the compound partnering business primarily in the United States. It collaborates with pharmaceutical and biotechnology companies to enhance the value of their drug candidates by applying its novel approach to drug development. The company’s products under development include Eluxadoline1, a mu opioid receptor agonist and delta opioid receptor antagonist, which is in Phase III clinical trials for the treatment of diarrhea-predominant irritable bowel syndrome; and Avarofloxacin1, a Phase III-ready fluoroquinolone antibiotic for the treatment of acute bacterial skin and skin structure infections. It is also developing SYR-472, which is in Phase III clinical trials for the treatment of Type-2 diabetes. In addition, the company has rights to compounds in various stages of development and commercialization, which includes Nesina, Liovel, Oseni, and Kazano for the treatment of Type-2 diabetes, as well as Priligy for the treatment of premature ejaculation. The company was founded in 1998 and is headquartered in Morrisville, North Carolina.
Cornerstone Therapeutics, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Cary, NC. To find more information about Cornerstone Therapeutics, Inc., please visit www.crtx.com